Alliance Pharma (APH)

 

APH Share PerformanceMore

52 week high56.00 02/06/17
52 week low40.50 27/06/16
52 week change 5.00 (10.99%)
4 week volume25,882,773 29/05/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Changes to interests of a significant shareholder

RNS Number: 9489I Alliance Pharma PLC 22 June 2017 For immediate release 22 June 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Changes to interests of a significant shareholder Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, has received a notification of a change in the interests of a significant shareholder. In accor...

Application for block admission

RNS Number: 7891I Alliance Pharma PLC 21 June 2017 For immediate release 21 June 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Application for block admission Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that it has today applied for a block admission for a further 25,000,000 ordinary shares of 1p each...

Changes to interests of a significant shareholder

RNS Number: 5070I Alliance Pharma PLC 19 June 2017 For immediate release 19 June 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Changes to interests of a significant shareholder Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, has received a notification of a change in the interests of a significant shareholder. In accord...

Application for admission

RNS Number: 4985I Alliance Pharma PLC 19 June 2017 For immediate release 19 June 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Application for admission Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that following the exercise of employee share options, application has been made by Alliance for a furt...

Application for admission

RNS Number: 1151I Alliance Pharma PLC 14 June 2017 For immediate release 14 June 2017 ALLIANCE PHARMA PLC ("Alliance" or the "Company") Application for admission Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that following the exercise of employee share options, application has been made by Alliance for a furth...

Changes to interests of a significant shareholder

Notification of major interests in shares

Result of AGM

Notification of the result of any voting at an AGM

Alliance Pharma cash flow remains strong

Alliance Pharma's cash flow remains strong and it is on target to reduce adjusted net debt/EBITDA ratio to around 2x by ...

Fundamental DataMore

P/E ratio13.117
EPS3.85
Dividend yield2.396 %

Equity Research (APH)

hardman & co
Alliance Pharma plc
25/05/2017
Alliance Pharma’s buy-and-build strategy to evolve into a profitable, cash generative, specialty pharma business is clearly bearing fruit. Acquisition of the dermatology and woundcare products from...
Alliance Pharma plc
01/02/2017
Early Equity (EEQP.NEX) 1.1p £7m FY Aug 16 results from the UK investment Company that provides equity and debt capital, along with strategic and operational counsel, to businesses that have the...
hardman & co
Alliance Pharma plc
25/01/2017
Alliance Pharma’s buy-and-build strategy to evolve into a profitable, cash generative, specialty pharma business is clearly bearing fruit. Acquisition of the dermatology and woundcare products from...

Latest discussion posts More

  • Re: Cheap, cheap, cheap.

    If this increase in share price keeps up, our dividends yield will look meager in comparison, despite it's 10% y-o-y increase.
    1-Jun-2017
    Ozonechemist
  • Re: Going Forward

    Unless the factory shuts down, like what happened to Ashton & Parson's a few years back. Thanks
    1-Jun-2017
    Ozonechemist
  • Re: Cheap, cheap, cheap.

    Should have lsitened to you. You didnt havee to wait for 6 months.
    1-Jun-2017
    claude reins

Users' HoldingsMore

Users who hold Alliance Pharma also hold..
LLOYDS GRP.26%
GLAXOSMITHKLINE18%
BP18%
NATIONAL GRID18%
TESCO14%

Codes & Symbols

ISINGB0031030819
SymbolsAPH, LSE:APH, APH.L, APH:LN, LON:APH, XLON:APH